BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36420706)

  • 1. lncRNA
    Shi C; Ren S; Zhao X; Li Q
    Pharmacogenomics; 2022 Dec; 23(18):973-985. PubMed ID: 36420706
    [No Abstract]   [Full Text] [Related]  

  • 2. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.
    Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S
    Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-chain non-coding RNA MALAT1 regulates paclitaxel resistance of breast cancer cells by targeting miR-485-3p].
    Aini S; Yan H; Ding W; Adi L; Su P
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):698-702. PubMed ID: 32897218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-Coding RNA MALAT1 Promotes Acute Cerebral Infarction Through miRNAs-Mediated hs-CRP Regulation.
    Teng L; Meng R
    J Mol Neurosci; 2019 Nov; 69(3):494-504. PubMed ID: 31342266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
    Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
    Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.
    Cao Y; Zhang F; Wang H; Bi C; Cui J; Liu F; Pan H
    Mol Cell Biochem; 2021 Jan; 476(1):279-292. PubMed ID: 32965597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer.
    Zheng L; Zhang Y; Fu Y; Gong H; Guo J; Wu K; Jia Q; Ding X
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis.
    Wu Q; Meng WY; Jie Y; Zhao H
    J Cell Physiol; 2018 Sep; 233(9):6750-6757. PubMed ID: 29226325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y; Li Y; Zhou Z; Ma M; Fu K
    Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p.
    Yue X; Wu WY; Dong M; Guo M
    Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA-PRLB Confers Paclitaxel Resistance of Ovarian Cancer Cells by Regulating RSF1/NF-κB Signaling Pathway.
    Zhao Y; Hong L
    Cancer Biother Radiopharm; 2021 Mar; 36(2):202-210. PubMed ID: 33156701
    [No Abstract]   [Full Text] [Related]  

  • 13. LncRNA MALAT1 inhibits apoptosis of endometrial stromal cells through miR-126-5p-CREB1 axis by activating PI3K-AKT pathway.
    Feng Y; Tan BZ
    Mol Cell Biochem; 2020 Dec; 475(1-2):185-194. PubMed ID: 32809092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
    Yang G; Zhang C; Wang N; Chen J
    Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis.
    Zhang H; Zhao B; Wang X; Zhang F; Yu W
    Life Sci; 2019 Jul; 228():135-144. PubMed ID: 31047896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Affects Paclitaxel Sensitivity of Ovarian Cancer Cells Through Autophagy Mediated by Long Noncoding RNASNHG7/miR-3127-5p Axis.
    Yu Z; Wang Y; Wang B; Zhai J
    Cancer Biother Radiopharm; 2022 Nov; 37(9):792-801. PubMed ID: 32522016
    [No Abstract]   [Full Text] [Related]  

  • 17. LncRNA-MALAT1/miRNA-204-5p/Smad4 Axis Regulates Epithelial-Mesenchymal Transition, Proliferation and Migration of Lens Epithelial Cells.
    Peng C; Wang Y; Ji L; Kuang L; Yu Z; Li H; Zhang J; Zhao J
    Curr Eye Res; 2021 Aug; 46(8):1137-1147. PubMed ID: 33327804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility.
    Zhuang M; Zhao S; Jiang Z; Wang S; Sun P; Quan J; Yan D; Wang X
    EBioMedicine; 2019 Mar; 41():286-298. PubMed ID: 30797712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J; Su ZZ; Shen QM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
    Peng Y; Fang X; Yao H; Zhang Y; Shi J
    Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.